218 related articles for article (PubMed ID: 22624025)
21. Diagnostic potential of serum miR-532-3p as a circulating biomarker for experimental intrinsic drug-induced liver injury by acetaminophen and cisplatin in rats.
Hwang DB; Seo Y; Lee E; Won DH; Kim C; Kang M; Jeon Y; Kim HS; Park JW; Yun JW
Food Chem Toxicol; 2023 Aug; 178():113890. PubMed ID: 37308052
[TBL] [Abstract][Full Text] [Related]
22. MiR-122-5p knockdown protects against APAP-mediated liver injury through up-regulating NDRG3.
Yang Z; Wu W; Ou P; Wu M; Zeng F; Zhou B; Wu S
Mol Cell Biochem; 2021 Feb; 476(2):1257-1267. PubMed ID: 33247804
[TBL] [Abstract][Full Text] [Related]
23. Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing.
Li D; Knox B; Gong B; Chen S; Guo L; Liu Z; Tong W; Ning B
Toxicol Sci; 2021 Jan; 179(1):31-43. PubMed ID: 33078836
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.
Yamaura Y; Tatsumi N; Takagi S; Tokumitsu S; Fukami T; Tajiri K; Minemura M; Yokoi T; Nakajima M
Clin Biochem; 2017 Dec; 50(18):1034-1039. PubMed ID: 28823616
[TBL] [Abstract][Full Text] [Related]
25. Screening the expression of several miRNAs from TaqMan Low Density Array in traumatic brain injury: miR-219a-5p regulates neuronal apoptosis by modulating CCNA2 and CACUL1.
Yan J; Bu X; Li Z; Wu J; Wang C; Li D; Song J; Wang J
J Neurochem; 2019 Jul; 150(2):202-217. PubMed ID: 31077370
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
27. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
28. Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAs.
Yamaura Y; Nakajima M; Tatsumi N; Takagi S; Fukami T; Tsuneyama K; Yokoi T
Toxicology; 2014 Aug; 322():89-98. PubMed ID: 24863736
[TBL] [Abstract][Full Text] [Related]
29. Comparison of microRNA expressions for the identification of chemical hazards in in vivo and in vitro hepatic injury models.
Hwang SR; Tham NTT; Lee SH; Bang JH; Yi H; Park YI; Lee HK; Kang HG; Kim YS; Woo GH; Ku HO
J Appl Toxicol; 2019 Feb; 39(2):333-342. PubMed ID: 30264499
[TBL] [Abstract][Full Text] [Related]
30. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.
Shi Q; Yang X; Mendrick DL
Biomark Med; 2013 Apr; 7(2):307-15. PubMed ID: 23547824
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs in Drug-induced Liver Injury.
Li LM; Wang D; Zen K
J Clin Transl Hepatol; 2014 Sep; 2(3):162-9. PubMed ID: 26357624
[TBL] [Abstract][Full Text] [Related]
33. Serum MicroRNAs as Potential Biomarkers of AMD.
Szemraj M; Bielecka-Kowalska A; Oszajca K; Krajewska M; Goś R; Jurowski P; Kowalski M; Szemraj J
Med Sci Monit; 2015 Sep; 21():2734-42. PubMed ID: 26366973
[TBL] [Abstract][Full Text] [Related]
34. The transformation in biomarker detection and management of drug-induced liver injury.
Church RJ; Watkins PB
Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
[TBL] [Abstract][Full Text] [Related]
35. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.
Cheng JL; Zhao H; Yang SG; Chen EM; Chen WQ; Li LJ
Hepatol Int; 2018 May; 12(3):277-287. PubMed ID: 29881991
[TBL] [Abstract][Full Text] [Related]
36. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
[TBL] [Abstract][Full Text] [Related]
37. The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice.
Qu XY; Tao LN; Zhang SX; Sun JM; Niu JQ; Ding YH; Song YQ
Environ Toxicol Pharmacol; 2017 Apr; 51():16-22. PubMed ID: 28262508
[TBL] [Abstract][Full Text] [Related]
38. Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats.
Lu X; Hu B; Zheng J; Ji C; Fan X; Gao Y
PLoS One; 2015; 10(10):e0141750. PubMed ID: 26512990
[TBL] [Abstract][Full Text] [Related]
39. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.
Yang X; Salminen WF; Shi Q; Greenhaw J; Gill PS; Bhattacharyya S; Beger RD; Mendrick DL; Mattes WB; James LP
Toxicol Appl Pharmacol; 2015 Apr; 284(2):180-7. PubMed ID: 25708609
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs as potential markers of human drug-induced liver injury.
Starkey Lewis PJ; Dear J; Platt V; Simpson KJ; Craig DG; Antoine DJ; French NS; Dhaun N; Webb DJ; Costello EM; Neoptolemos JP; Moggs J; Goldring CE; Park BK
Hepatology; 2011 Nov; 54(5):1767-76. PubMed ID: 22045675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
